Standard BioTools (LAB) is One of the Best Life Sciences Penny Stocks, Here is Why [Yahoo! Finance]
Standard BioTools Inc. (LAB)
Company Research
Source: Yahoo! Finance
As of the April 8 close, Standard BioTools Inc. (NASDAQ:LAB) had a neutral consensus sentiment. The stock received 2 Hold ratings from analysts, with a projected median 1-year price target of $1.35. This yields an impressive upside potential of more than 52%. Likoper/Shutterstock.com On March 16, Ark Invest revealed changes to some of its existing holdings, including reductions across some of the smaller genomics stocks. The investment management firm exited some portion of its Standard BioTools Inc. (NASDAQ:LAB) holdings. In late February, Michael Egholm, President & CEO, reflected on the company's fourth quarter results. He described the passing year as a good one for the company, highlighting that the company was able to beat expectations through efficient processes being followed across the organization. Egholm also noted that the company has been able to remain focused on efficiency due to the fact that it successfully implemented roughly $40 million worth of cost synerg
Show less
Read more
Impact Snapshot
Event Time:
LAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LAB alerts
High impacting Standard BioTools Inc. news events
Weekly update
A roundup of the hottest topics
LAB
News
- Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026GlobeNewswire
- Standard BioTools (LAB) was downgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=LAB&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "hold" MarketBeat
- Standard BioTools: Q4 Earnings Snapshot [Yahoo! Finance]Yahoo! Finance
- Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswire
- Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026GlobeNewswire
LAB
Earnings
- 2/24/26 - Beat
LAB
Sec Filings
- 4/24/26 - Form 8-K
- 4/8/26 - Form 4
- 4/8/26 - Form 4
- LAB's page on the SEC website